• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » J&J nabs its 1st Chinese device maker | Wall Street Beat

J&J nabs its 1st Chinese device maker | Wall Street Beat

May 3, 2012 By MassDevice staff

MassDevice.com Wall Street Beat

Health care giant Johnson & Johnson (NYSE:JNJ) made its 1st acquisition in China this week, picking up Guangzhou Bioseal Biotech for an undisclosed amount.

J&J has been doing business in China for more than 25 years, including last year’s launch of a medical device and diagnostics innovation center there.

"This transaction reinforces our commitment to China and delivering innovative medical device solutions to the Chinese market," J&J’s Chinese medical president Xie Wen Jian said in prepared remarks. "We are very pleased to add the Bioseal brand to our growing portfolio of hemostasis products in China and we look forward to working with our new Bioseal colleagues to bring their innovative products to more physicians and patients."

Bioseal developed a sealant used to control bleeding during surgery, the only porcine plasma-derived fibrin sealant approved for use in China, according to a press release.

The newly acquired company will work alongside J&J’s Ethicon subsidiary, which already markets its Surgical and Surgiflow biosurgery products in China.

 Aethlon expects $1.4M in full-year revenues
Aethlon Medical (OTC:AEMD), which last year notched its 1st-ever revenues with a $6.8 million contract with the Defense Advanced Research Projects Agency, advised investors that it expects to post $1.4 million in revenue for its March 31, 2012 fiscal year end. Read more

 Washington group pushes women’s pelvic health

Personal Medical Corp., a Redmond, Wash.-based medical device maker dedicated to advancing women’s pelvic health, announced its official launch this week. The company was previously a wholly owned subsidiary of SRS Medical in Billerica, Mass., whose founder and former CEO Kevin Connolly will take the helm at Personal Medical.

Personal Medical’s portfolio includes the inFlow device, which it touts as the 1st technology solution for women with neurogenic underactive bladder, as well as the Restore Continence suite of devices for treating of urinary incontinence and prolapse.  Read more

 Invest in R&D, survey says
Although many industries boost shareholder value by reinvesting in the company, but device makers may do well to put their money toward research & development, an analysis by CFO.com. The group noted that in its analysis of the 30 largest publicly traded U.S. med-tech companies, those that reinvested in R&D outperformed their peers by 11% in terms of total shareholder return.  Read more

 GPOs: Novation signs pulse oximetry deals with Masimo, Nonin Medical

Masimo (NSDQ:MASI) signed a 3-year deal to supply SET and Rainbow SET pulse oximetry systems to members of Novation. The group purchasing organization also signed a pulse oximetry deal with Nonin Medical. Read more

 Funding Roundup

  • Infection control systems maker Nanosonics looks to raise $12M at 53¢ per share
  • Image Stream Medical raises $600k in equity from 3 investors

 Analysts’ ups and downs

  • Allergan (NYSE:AGN): Jeffries raises price target to $95, maintains "hold" rating
  • AthenaHealth (NSDQ:ATHN): Morgan Stanley upgrades to "equal-weight" rating
  • AtriCure (NSDQ:ATRC): Leerink Swann maintains "outperform" rating, $14 price target
  • Edwards Lifesciences (NYSE:EW): Cannacord Genuity maintains "positive" rating
  • LeMaitre Vascular (NSDQ:LMAT): Cannacord Genuity lowers price target from $7.50 to $7, maintains "buy" rating
  • Smith & Nephew (FTSE:SN): Numis upgrades to "buy" rating, maintains 740p price target
  • Staar Surgical Co. (NSDQ:STAA): Cannacord Genuity lowers price target from $14.50 to $14, maintains "buy" rating
  • Teleflex (NYSE:TFX): Jeffries maintains "hold" rating, ups price target from $60 to $64
  • Volcano (NSDQ:VOLC): Leerink Swann maintains "outperform" rating, $33 price target
  • Wright Medical (NSDQ:WMGI): Leerink Swann maintains "market perform" rating, ups price target from $19 to $20

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Aethlon Medical Inc., Deals Roundup, Johnson and Johnson, Masimo, Nonin Medical Inc., Novation, Personal Medical Corp.

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy